JP6155266B2 - ゾニサミドを含有する経皮吸収型製剤 - Google Patents

ゾニサミドを含有する経皮吸収型製剤 Download PDF

Info

Publication number
JP6155266B2
JP6155266B2 JP2014528202A JP2014528202A JP6155266B2 JP 6155266 B2 JP6155266 B2 JP 6155266B2 JP 2014528202 A JP2014528202 A JP 2014528202A JP 2014528202 A JP2014528202 A JP 2014528202A JP 6155266 B2 JP6155266 B2 JP 6155266B2
Authority
JP
Japan
Prior art keywords
group
ether
sec
tert
polyoxyethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014528202A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2014021393A1 (ja
Inventor
和充 山本
和充 山本
雅康 田中
雅康 田中
弘雄 前田
弘雄 前田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Publication of JPWO2014021393A1 publication Critical patent/JPWO2014021393A1/ja
Application granted granted Critical
Publication of JP6155266B2 publication Critical patent/JP6155266B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2014528202A 2012-08-01 2013-07-31 ゾニサミドを含有する経皮吸収型製剤 Expired - Fee Related JP6155266B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012171433 2012-08-01
JP2012171433 2012-08-01
PCT/JP2013/070791 WO2014021393A1 (fr) 2012-08-01 2013-07-31 Préparation pharmaceutique de type absorption transdermique contenant du zonisamide

Publications (2)

Publication Number Publication Date
JPWO2014021393A1 JPWO2014021393A1 (ja) 2016-07-21
JP6155266B2 true JP6155266B2 (ja) 2017-06-28

Family

ID=50028063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014528202A Expired - Fee Related JP6155266B2 (ja) 2012-08-01 2013-07-31 ゾニサミドを含有する経皮吸収型製剤

Country Status (2)

Country Link
JP (1) JP6155266B2 (fr)
WO (1) WO2014021393A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150102727A (ko) * 2014-02-28 2015-09-07 교와 가부시키가이샤 유중수형 유화 조성물
EP3434269B1 (fr) * 2016-03-25 2020-12-23 Teikoku Seiyaku Co., Ltd. Préparation pharmaceutique sous forme de timbre transdermique à absorption percutanée comprenant un zonisamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11189546A (ja) * 1997-12-25 1999-07-13 Saitama Daiichi Seiyaku Kk 経皮吸収促進剤
CN1149084C (zh) * 1997-12-26 2004-05-12 大日本制药株式会社 治疗神经变性病药物
US20040241240A1 (en) * 2001-08-10 2004-12-02 Takaaki Terahara Percutaneous absorption preparations
AU2011248904B2 (en) * 2010-04-30 2014-02-27 Teikoku Seiyaku Co., Ltd. Propynylaminoindan transdermal compositions

Also Published As

Publication number Publication date
JPWO2014021393A1 (ja) 2016-07-21
WO2014021393A1 (fr) 2014-02-06

Similar Documents

Publication Publication Date Title
JP5001271B2 (ja) 新規テープ製剤
US20220062421A1 (en) Transdermal cancer antigen peptide preparation
KR101848961B1 (ko) 로피니롤 함유 첩부제 및 그 포장체
KR101844625B1 (ko) 로피니롤 함유 첩부제 및 그 포장체
JP2003284739A (ja) シ−ト状貼付剤
KR101942677B1 (ko) 첩부제
JP2016106133A (ja) 経皮吸収促進剤及びそれを含有する経皮吸収型製剤
JP5837518B2 (ja) 経皮吸収用貼付製剤
FI107705B (fi) Lanoliinijohdannaiset penetraatiota edistävinä aineina ja niiden käyttö lääkeaineita tai muita biologisesti aktiivisia aineita sisältävissä valmisteissa
JP6155266B2 (ja) ゾニサミドを含有する経皮吸収型製剤
US5925373A (en) Transdermal delivery device containing an estrogen
JPH06135828A (ja) 経皮吸収性製剤
JP5913335B2 (ja) 新規外用製剤
JP2001233764A (ja) Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤
JPH10204000A (ja) 経皮吸収促進剤
JPS61178915A (ja) 血圧降下用経皮吸収剤
JPH10316825A (ja) 粘着性組成物
WO2017011611A1 (fr) Système d'administration pharmaceutique pour l'application transdermique de vardénafil
JPH10120593A (ja) 抗真菌外用剤
CA2555366A1 (fr) Remede a usage externe pour lesions de la peau et des muqueuses causees par infection virale

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170117

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170303

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170314

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170303

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170406

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170418

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170512

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170530

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170605

R150 Certificate of patent or registration of utility model

Ref document number: 6155266

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees